MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
Mutual FundPosition in BCAX — Bicara Therapeutics Inc.
CIK 1705339
CAUSEWAY BAY, K3
Position in BCAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$351,376
+$46,081 QoQ
Shares Held
17,666
-2.6% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BCAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $430,178,526 across 240 Biotechnology names. BCAX ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
171,925 | $76,771,388 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,854 | $53,971,993 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
81,325 | $26,908,001 | |
| 4 | INSM |
INSMED Inc
|
122,958 | $20,106,091 | |
| 5 | RPRX |
Royalty Pharma plc
|
419,129 | $20,105,617 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
27,744 | $8,938,838 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
139,598 | $8,752,793 | |
| 8 | MRNA |
Moderna, Inc.
|
147,589 | $7,497,520 |
All Filings in BCAX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $351,376 | 17,666 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $305,295 | 18,140 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $254,376 | 16,110 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $173,992 | 18,729 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $148,216 | 11,375 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $189,999 | 10,907 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||